SPRC Stock Catalyst: SciSparc Subsidiary NeuroThera Labs Granted Japanese Patent for Therapeutic Combination

Aug 12, 2026 · 8:30am ET

The patent covers NeuroThera Labs' proprietary therapeutic combination.

Max move

+37.5%

High of day $9.90

Sparker timei

8:30am ET

SPRC · Aug 12, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

SciSparc Ltd. announced on August 12, 2026, that its subsidiary NeuroThera Labs has been granted a patent in Japan for its proprietary therapeutic combination.

The patent recognition underscores the innovative nature of NeuroThera Labs' therapeutic approach.

SciSparc Ltd. has a free float of 57,798 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time SPRC sparks.

Download Sniper App →

Catch the next SPRC-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →